Rebound Therapeutics
Irvine
About Rebound Therapeutics
Rebound has progressed rapidly over the past 18 months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive surgical procedures. In addition to rapid product development of its initial products, Rebound has assembled a world-class Scientific Advisory Board of leading MIS physicians, filed 14 patents to solidify its intellectual property platform and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $16.5M
- Funding stage: M&A
- Last round: Series B (Jul 2017)
- Website: reboundtx.com
- Phone: (949)581-7250
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/rebound-therapeutics-113784 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.